Table 3 Patient cohort used to test commercially available FibroGRO fibroblast cell growth media.

From: cGMP production of patient-specific iPSCs and photoreceptor precursor cells to treat retinal degenerative blindness

Patient

Age

Sex

FibroGROâ„¢

T3

29

Male

++

T2

36

Male

+

T1

47

Male

+

T7

56

Male

−

T4

61

Male

−

T6

79

Female

−

T5

81

Male

−

  1. Age = age at biopsy; ++ = by 14-days post-platting a sufficient number of dermal fibroblasts for iPSC generation were present; + = by 14 days post-plating dermal fibroblasts were present however, they were sparse and not sufficient for iPSC generation; −at 14-days post-platting few if any dermal fibroblasts were present.
Back to article page